Evidence map›Paper›PMID 41426083›Full record

ArticleNanophotonics (Berlin, Germany)2025

Disentangling the absorption lineshape of methylene blue for nanocavity strong coupling.

Santiago A Gomez, Emmi K Pohjolainen, Dmitry Morozov, Ville Tiainen, J Jussi Toppari, Gerrit Groenhof

Abstract readLetter
In one paragraph

Article in Nanophotonics (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Santiago A GomezNanoscience Center and Department of Chemistry, University of Jyväskylä, P.O. Box 35, 40014 Jyväskylä, Finland.
Emmi K PohjolainenNanoscience Center and Department of Chemistry, University of Jyväskylä, P.O. Box 35, 40014 Jyväskylä, Finland.
Dmitry MorozovNanoscience Center and Department of Chemistry, University of Jyväskylä, P.O. Box 35, 40014 Jyväskylä, Finland.
Ville TiainenNanoscience Center and Department of Physics, University of Jyväskylä, P.O. Box 35, 40014 Jyväskylä, Finland.
J Jussi ToppariNanoscience Center and Department of Physics, University of Jyväskylä, P.O. Box 35, 40014 Jyväskylä, Finland.ORCID https://orcid.org/0000-0002-1698-5591
Gerrit GroenhofNanoscience Center and Department of Chemistry, University of Jyväskylä, P.O. Box 35, 40014 Jyväskylä, Finland.ORCID https://orcid.org/0000-0001-8148-5334

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cucurbit[7]uril molecules form non-covalent host - guest complexes with small molecular dyes. In addition, cucurbit[7]uril can also bind gold nanoparticles on gold surfaces with a 0.9 nm gap, creating plasmonic nanocavities for the dyes, with extreme confinement of the electromagnetic field. For methylene blue in such cavities, single molecule strong coupling was inferred from a complete disappearance of a characteristic shoulder in its spectrum, attributed to dimer removal. Yet, the shoulder's origin remains debated. Using atomistic simulations, we show that it arises from both dimerization and vibronic progression. While cucurbit[7]uril binding removes the dimer contribution, vibronic progression persists. As this conflicts with previous reports, we also measured the spectra. In line with our computations, the shoulder remains visible when cucurbit[7]uril binds methylene blue. These results clarify the spectral features and pave the way for atomistic models of single-molecule strong coupling in nanoparticle-on-mirror cavities.

Indexed as

absorption spectracucurbiturilmethylene blueplasmonic nanocavitystrong couplingvibronic progression

Identifiers

PMID41426083
PMCPMC12717915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.